Live Breaking News & Updates on கேம்பிரிட்ஜ் துறை ஆஃப் மருந்து
Stay updated with breaking news from கேம்பிரிட்ஜ் துறை ஆஃப் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Systematic review finds that machine learning models for detecting and diagnosing COVID-19 from medical images have major flaws and biases, making them unsuitable for use in patients. However, researchers have suggested ways to remedy the problem. ....
DNA test can help identify pneumonia in severe COVID-19 patients: Study PTI London: Cambridge scientists have developed a simple DNA test that can quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation. Mechanical ventilation is often the only way to keep patients with the most severe forms of COVID-19 alive, as doctors use anti-inflammatory therapies to treat their inflamed lungs, the researchers said. However, these patients are susceptible to further infections from bacteria and fungi that they may acquire while in hospital –- so called ‘ventilator-associated pneumonia’. Now, researchers at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust have developed a DNA test to quickly identify these infections and target antibiotic treatment as needed. ....
Cambridge [UK], January 15 (ANI): A team of scientists and doctors from the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust have developed a DNA test which they claim will quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation. ....
Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients. ....
London, January 15 Cambridge scientists have developed a simple DNA test that can quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ....